These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1657632)

  • 21. Acute exposure to acid fog. Effects on mucociliary clearance.
    Laube BL; Bowes SM; Links JM; Thomas KK; Frank R
    Am Rev Respir Dis; 1993 May; 147(5):1105-11. PubMed ID: 8484617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The differential effect of aspirin on human platelet activation in aspirin-sensitive asthmatics and normal subjects.
    Taylor ML; Stewart GA; Thompson PJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):227-34. PubMed ID: 8471399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of 5-lipoxygenase products in the development of airway responsiveness induced by platelet activating factor inhalation in dogs].
    Imai T; Adachi M; Idaira K; Takahashi T; Saito C; Maeda M; Tsuji A
    Arerugi; 1991 Apr; 40(4):454-63. PubMed ID: 1854258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled platelet-activating factor causes pulmonary neutrophil sequestration in normal humans.
    Tam FW; Clague J; Dixon CM; Stuttle AW; Henderson BL; Peters AM; Lavender JP; Ind PW
    Am Rev Respir Dis; 1992 Oct; 146(4):1003-8. PubMed ID: 1416388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of leukotriene B4 inhalation on airway responsiveness in dogs].
    Imai T; Nambu F; Adachi M; Takahashi T; Saito C; Maeda M; Tsuji A
    Arerugi; 1990 Oct; 39(10):1380-7. PubMed ID: 2175594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.
    Gómez FP; Iglesia R; Roca J; Barberà JA; Chung KF; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1559-64. PubMed ID: 9603138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans.
    Taylor IK; Ward PS; Taylor GW; Dollery CT; Fuller RW
    J Appl Physiol (1985); 1991 Oct; 71(4):1396-402. PubMed ID: 1661723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prostacyclin on bronchoconstriction and neutropenia induced by inhaled platelet-activating factor in man.
    Lammers JW; Kioumis I; McCusker M; Nichol GM; Barnes PJ; Chung KF
    J Allergy Clin Immunol; 1990 Apr; 85(4):763-9. PubMed ID: 2109002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression.
    Gabrijelcic J; Acuña A; Profita M; Paternò A; Chung KF; Vignola AM; Rodríguez-Roisin R
    Eur Respir J; 2003 Aug; 22(2):290-7. PubMed ID: 12952263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite effects of inhaled bradykinin and [desArg9]-bradykinin on tracheobronchial clearance in normal humans.
    Polosa R; Hasani A; Cacciola RR; Colombrita R; Agnew JE; Clarke SW; Holgate ST
    Monaldi Arch Chest Dis; 1996 Apr; 51(2):112-6. PubMed ID: 8680375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man.
    Cuss FM; Dixon CM; Barnes PJ
    Lancet; 1986 Jul; 2(8500):189-92. PubMed ID: 2873440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of inhaled platelet-activating factor on circulating neutrophils and platelets in vivo and ex vivo in man.
    Kioumis I; Lammers JW; Dent G; Chung KF; Barnes PJ
    Prostaglandins; 1988 Sep; 36(3):343-54. PubMed ID: 3237997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects.
    Roberts NM; McCusker M; Chung KF; Barnes PJ
    Br J Clin Pharmacol; 1988 Jul; 26(1):65-72. PubMed ID: 3203062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet activating factor compromises airway epithelial defense functions.
    Ohashi Y; Nakai Y; Morimoto K; Tanaka A; Kakinoki Y; Ohno Y; Masamoto T; Kato A
    J Allergy Clin Immunol; 1997 Oct; 100(4):520-6. PubMed ID: 9338547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of inhaled 15-(s)-hydroxyeicosatetraenoic acid on tracheobronchial clearance in normal human airways.
    Lai CK; Polosa R; Pavia D; Hasani A; Agnew JE; Clarke SW; Holgate ST
    Thorax; 1991 Jun; 46(6):446-8. PubMed ID: 1858085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of inhaled histamine on human tracheal mucus velocity and bronchial mucociliary clearance.
    Mussatto DJ; Garrard CS; Lourenco RV
    Am Rev Respir Dis; 1988 Oct; 138(4):775-9. PubMed ID: 3202450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salbutamol inhibits pulmonary effects of platelet activating factor in man.
    Roca J; Félez MA; Chung KF; Barberà JA; Rotger M; Santos C; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1740-4. PubMed ID: 7767515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood.
    Sieunarine K; Lawrence-Brown MM; Goodman MA; Prendergast FJ; Rocchetta S
    Vox Sang; 1992; 63(3):168-71. PubMed ID: 1333134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salbutamol reduces pulmonary neutrophil sequestration of platelet-activating factor in humans.
    Masclans JR; Barberà JA; MacNee W; Pavia J; Piera C; Lomeña F; Chung KF; Roca J; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):529-32. PubMed ID: 8756833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effect of inhaled bradykinin on tracheobronchial clearance in normal humans.
    Polosa R; Hasani A; Pavia D; Agnew JE; Lai CK; Clarke SW; Holgate ST
    Thorax; 1992 Nov; 47(11):952-6. PubMed ID: 1465754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.